HIG heads into Thursday's formal earnings release at $140.53, down 1.2% on Friday, even as its closest insurance peers posted broad gains — a divergence that frames the question the print must answer.
The peer gap is the standout. TRV gained 2.9% on the day and nearly 5% on the week. ACGL added 3.3%. ALL rose 2.1%. HIG gave back ground across all of them, sitting roughly flat on the week against a cohort that averaged gains of 2–3%. Options positioning reflects that cooling: the put/call ratio has ticked back toward 0.42, well below its 20-day average of 0.69 and nearly 1.4 standard deviations on the call-heavy side — but the dramatic call skew from the July 20 preview has faded materially since the July 23 release. The lending market remains a non-story, with borrow availability at 8,690% and cost to borrow near 0.37% — there is no short pressure of any kind.
The analyst picture is genuinely split. Wells Fargo, Mizuho, and Cantor Fitzgerald lifted targets to $165, $163, and $158 respectively in early July, reflecting confidence in the core P&C business. JP Morgan followed with a nudge to $152 on July 20. But Piper Sandler cut to Neutral on July 15 — flagging reserve adequacy, retention trends, and the risk of hurricane exposure — and the consensus remains at hold with a mean target of $149.05, only modestly above the current price. The bear case centres on the $150 million after-tax loss from the Wellington asset management sale and the near-term earnings drag from the transition; bulls argue the deal's buyback-driven accretion offsets that pain over time.
Thursday's release will test whether Hartford's P&C margins held through the quarter and whether management's confidence in the Wellington deal's long-run accretion is enough to pull the stock back in line with a peer group that has clearly moved ahead of it.
See the live data behind this article on ORTEX.
Open HIG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
